Doctor Profile

Vivian W. Bucay
MD

Vivian Bucay
MD

Bucay Center for Dermatology and Aesthetics
326 W Craig Place
San Antonio, TX 78212

San Antonio

Texas (TX)

Contact Contact Vivian W. Bucay
T: 210-692-3000

Visit: www.drvivianbucay.com
Dermatology
Doctor's practice offers cosmetic/reconstructive procedures

Dermatology

Languages Spoken: English, Spanish

Profile

A graduate of the Johns Hopkins University and Baylor College of Medicine, Dr. Vivian Bucay, a board certified dermatologist, opened her private practice in 1991. She serves on the volunteer faculty at the University of Texas Health Science Center in San Antonio. Known for her expertise in minimally invasive aesthetics, Dr. Bucay is sought nationally and internationally for speaking engagements. Not only published in medical journals, she is regularly quoted in many nationally recognized publications, such as Allure, Good Housekeeping and Men’s Health. Second location: 18707 Hardy Oak Blvd., Suite 101. Ph: 210-370-9995.

Published In:

Texas Super Doctors 2023
Texas Super Doctors 2022
Texas Super Doctors 2021
Texas Super Doctors 2020
Texas Super Doctors 2019
Texas Super Doctors 2018
Texas Super Doctors 2017
Texas Super Doctors 2016
Texas Super Doctors 2015
Texas Super Doctors 2014
Texas Super Doctors 2013
Texas Super Doctors 2012
Texas Super Doctors 2011
Texas Super Doctors 2010
Texas Super Doctors 2009
Texas Super Doctors 2008
Texas Super Doctors 2007
Texas Super Doctors 2006
Texas Super Doctors 2004

About Vivian Bucay

Medical School: Baylor College of Medicine

Graduation Year: 1987

Professional Webpage: www.drvivianbucay.com

Honors and Awards:

SA Current

What you hold in your hands or read on your screen is a massive ode to the majority vote. 

In a world where decision making is messy, in a year when we will use and arcane system to pick our country's next leader, the majority vote is simple and clean and cutthroat. And it is how we assembled the winners of Best of San Antonio 2016.  

San Antonio Current Best Dermatologist of 2016 , http://www.sacurrent.com/, 2016

The Patient Institute - Educating Patients. Empowering You.

Dr. Bucay was honored for using her experiences as patients to educate and advocate for others requiring similar care.  Vivian Bucay, M.D.  Vivian, a renowned dermatologist, had been diagnosed with Melanoma, the deadliest form of skin cancer. Vivian went on to tell the story of her self-diagnosis, her treatments, finding out that the Melanoma was Stage four and had spread to her lungs, and the irony of her being a doctor suffering with the disease that she is meant to diagnose in others. She mentioned that she writes articles and gives lectures throughout the world about her experience. Dr. Bucay has been blessed with being cancer-free and having good prognoses. The Patient Institute educates patients and provides them with tools that they need to more successfully navigate the healthcare system!

2014

North Star Gives Will Honor Eight Women and Men Who Inspire Change

SAN ANTONIO (February 7, 2014) — North Star Gives, presented by North Star Mall in partnership with Saks Fifth Avenue honors people who crusade for public good, 6 to 8 p.m., Thursday, March 20, in the Saks Fifth Avenue wing.  The eight women and men being recognized this year include: Suhail Arastu, Musical Bridges Around the World; Di-Anna Arias, Time Dollar Community Garden; Louis Barrios, Viola's Huge Heart; Peggy Brink, Care; Dr. Vivian Bucay, Respite Care; Jason Cox, Marrow Me; Katy Flato, San Antonio Public Library Foundation; and Beth Webster-Wright, The San Antonio Furniture Bank.  

 Now in its fourth year, the annual spring event celebrates champions of change who affect our community in a rich kaleidoscope of ways.  Whether driven by personal quests or just a sincere desire to make a difference, the people honored set inspiring examples of the meaning of volunteerism and advancing the quality of life for others. 

Dr. Vivian Bucay, Respite Care San Antonio

Respite Care provides services to enhance the stability and the nurturing opportunities of families caring for a loved one with a developmental disability. Respite Care is a place for parents and families to regroup from the constant pressures of care and caring.  It is a place where their children – who don't quite 'fit in' by some definitions – can participate, be cared for and be celebrated for the individuals they are. Respite Care has also become a safe haven for children who have been victims of abuse or neglect. Encompassing a series of services and programs administered by professionally trained caregivers in multiple locations throughout San Antonio, Respite Care offers full-service child daycare, an emergency shelter, foster placement and part time day out programs. Most programs are for the child with special needs, as well as siblings.  To support this great cause visit www.drvivianbucay.com.

 

2014

National Merit Scholar ,

Special Licenses/Certifications:

Texas

Mexico

American Board of Dermatology -Board Recertification-2001.2011

Professional Activity:

  • MEDIA EXPERIENCE
  • Television “Un Nuevo Dia” — Discussed Facial Rejuvenation using laser resurfacing. June 1998, Mexico City, Mexico.
  • WOAI NBC Affiliate Television Station, San Antonio, TX- Dermatology expert with regular television appearances on the LIVING SHOW to discuss various topics about medical and cosmetic dermatology, 2002-2008
  • KENS CBS Affiliate television station, San Antonio, TX
  • News segments on various topics in medical and cosmetic dermatology Univision 41, Univision Affiliate San Antonio, TX- Featured dermatologist since 2001 on the talk show DESDE SAN ANTONIO regarding skin problems in Hispanics
  • Print media: quoted in San Antonio Express-News, Cosmetic Surgery Times, Dermatology Times, Skin and Allergy News, Plastic Surgery Practice, New Beauty, Allure, Shape, More, Good Housekeeping, Fitness, and Elle Magazine.

CONSULTANT/ADVISORY BOARD/SPEAKER BUREAU(*cosmeceuticals)


Allergan, Inc- consultant and speaker
Galderma/Nestlé Skin Health, consultant and speaker

MERZ-consultant and speaker

Evolus-advisor

Neutrogena and AVEENO division of Johnson and Johnson-consultant

*Sente Labs-Lead Medical Advisor

*Medicell Technologies-Medical advisory board

*Alastin Skincare, Inc, Medical advisory board

*SiennaBiopharmaceuticals-medical advisory board

*Biopelle/Ferndale-consultant and speaker

Laboratorios ISDIN (Spain) - consultant

*Clarisonic- consultant

Bioderma-consultant

Cynosure/Elman International, Inc.-speaker and investigator

*Skinceuticals (L'Oreal) -advisor and speaker

BTL Aesthetics-consultant and speaker

*Neostrata-speaker

Viviscal, Inc.

Procter and Gamble

AVEENO division of Johnson and Johnson
Ortho Neutrogena Division of Johnson and Johnson
Novartis Pharmaceuticals
Bioform/Merz
Biopelle/Ferndale
Galderma
Laboratorios ISDIN (Spain)
HydropeptideApril Rain Skin Science (Guiding dermatologist)
Syneron Topical Aesthetics
Ellman International, Inc.


MEETING PRESENTATIONS

  1. Television “Un Nuevo Dia” — Discussed Facial Rejuvenation using laser resurfacing. June 1998, Mexico City, Mexico.
  2. Dermatology Nurses Association monthly meeting. Discussed Tazarotene in the treatment of acne vulgaris. Houston, Texas. August 2000.
  3. Headed Round Table Discussion of Tazarotene in the treatment of acne vulgaris and anti- aging. New Orleans, Louisiana. September 2000.
  4. Society for Cosmetic Physicians of Western Australia — Guest Speaker: The Art of Facial Rejuvenation. Perth, Western Australia March 2002
  5. Co-Chair for Asia Pacific Expert Injectors Conference — Guest Speaker: Advanced Applications of Botox. Gave course and led workshop at the conference. Bali, Indonesia March 2002
  6. Advances in Facial Contouring, Vancouver, Canada. August 2003
  7. Annual meeting of the Society for Dermatology Physician Assistants — Guest Speaker: The Art of Facial Rejuvenation. San Antonio, Texas November 15, 2003
  8. American Society for Cosmetic Dermatology and Aesthetic Surgery: “The Use of Fillers in Facial Rejuvenation.” Las Vegas, Nevada December 2003
  9. 20th Annual Update Dermatology and All that Jazz 2004 Conference, sponsored by Tulane University, “The use of Fillers for Facial Aesthetic Enhancement. New Orleans, Louisiana April 2004
  10. American Society of Aesthetic and Plastic Surgery: “The Evolving Use of Botulinum Toxin and Fillers in Facial Rejuvenation.” Chicago, Illinois, September 2005
  11. Skin Disease Education Foundation Meeting – Women’s and Pediatric Dermatology: “The Evolving Use of Botulinum Toxin and Fillers in Facial Rejuvenation.” San Antonio, Texas, September 2006.
  12. Keynote Speaker at the KLRN Women’s Health Conference, Laredo, Texas. January 2007.
  13. Co-chair for CME-approved course, “Shaping the Course of Aesthetic Medicine: Advanced Techniques.” San Antonio, Texas, February 2007.
  14. Keynote Speaker at the Annual Women in Medicine Dinner of the Bexar County Medical Society, San Antonio, Texas, September 2007.
  15. Faculty, Facial Aesthetics National Exchange Forum Consultant Meeting, The Science of Rejuvenation, sponsored by Allergan, San Diego, California, 2008
  16. Texas Dermatological Association, annual spring meeting, “The Evolving Use of Botulinum Toxin and Fillers,” San Antonio, Texas, May 2008
  17. Co-chair for CME- approved course, “Injector Training Regional Symposium,” Austin, Texas, Aug. 9, 2008
  18. Speaker for CME series “Differentiating Among Hyaluronic Acid Fillers,” Presentations given in San Jose, San Diego, Phoenix, Houston, Dallas, and New York City during September, October, and November, 2008
  19. Steering Committee and Faculty, Advances in Cosmetic Therapy (ACT) CME Initiative: Advances in Cosmetic Therapy: A Focus on BoNT-A. October 2008, patient injections and filming in preparation for Curriculum Content Development Meeting, Dallas, TX, December 2008. Faculty speaker for meetings in Miami, FL, Sept 2009, Jacksonville, FL, Oct 2009, and San Antonio, TX, Oct 2009. Santa Fe, NM, Jan 2010
  20. Faculty, PALETTE (Progressive Aesthetic Learning Essential to Technical Expertise) CME Initiative, 2009, 2010, 2011, 2012. Course leader of hands-on workshops held throughout the US
  21. Guest Speaker, Annual Meeting of the AVEENO/Neutrogena sales force, “Sun protection for health and Beauty,” Dallas, Texas, January 2009
  22. Guest Speaker, Annual Meeting of the Novartis Pharmaceuticals sales force, oncology division, “Surviving Stage 4 Melanoma: A Patient’s Perspective,” Orlando, FL, June 2009
  23. Guest Speaker, BODY Conference 2009, “Laser and Light Based Cellulite Treatment,” Royal College of Physicians, London, UK, November 2009
  24. Keynote Address, Annual Meeting of the Society of Dermatology Physician Assistants, “Surviving Advanced Melanoma,” Scottsdale, AZ, November 14, 2009
  25. Faculty, Cosmetic Surgery Forum 2009, Faculty Panels: Treatment Strategies for Hyperpigmentation; Cosmeceuticals in Clinical Practice; Fillers, Las Vegas, Nevada, Dec 4-6, 2009
  26. Invited Guest Speaker, Annual meeting of SEME (Sociedad Espanola de Medicina Estetica), “Topical Anesthetics for Medical and Cosmetic Procedures in Dermatology,” Barcelona, Spain, Feb. 2010
  27. Invited Speaker, Second Annual Dysport Meeting (Galderma, Brazil), “Combination Treatment with BoNT-A, Fillers, and Lasers,” Fort Lauderdale, FL, March 2010
  28. Faculty, Integrating New Neuromodulators CME Initiative, Hands-on instructional workshops, Austin, TX, April 2010, San Antonio, TX, June 2010
  29. Faculty Speaker, Combined Meeting of the ASDS and ASCDAS, “Medical Presentations, Photography, and Patient Confidentiality,” Chicago, IL, Oct. 2010
  30. Invited Guest Speaker, “Treatment Strategies for Melasma and Hyperpigmentation,” Elure (Syneron Topical Aesthetics) World Launch Media Event, Singapore, Nov. 2010
  31. Invited Guest Speaker, Annual Meeting of the Society of Dermatology Physician Assistants, “Combined Use of Fillers and Neuromodulators in Facial Aesthetics,” and “Fillers for Facial Contouring,” Grapevine, TX, Nov. 2010
  32. Faculty, Cosmetic Surgery Forum, Las Vegas, NV, Dec. 2010
  33. Medscape Education Dermatology CME Videos (3). “Aesthetic Use of Neurotoxins: Safety and Informed Consent,” December 28, 2010. “Doses and Units in the Aesthetic use of Neurotoxins,” January 28, 2011. “Patient Satisfaction During Aesthetic Neurotoxin Treatment,” February 22, 2011.
  34. Faculty, Annual Meeting of the American Academy of Dermatology, “Managing Filler Complications,” New Orleans, LA, Feb. 2011
  35. Poster, “A case report of lignin peroxidase lotion used to treat post-inflammatory hyperpigmentation in skin type V,” presented at the Skin of Color Seminar Series, New York City, May 14, 2011.
  36. Faculty, 7th Annual Cosmetic Surgery Vegas, Presentations: “Coordination of the Aesthetic Team,” June 25, 2011 and Masters Session “Step by Step Nonsurgical Facial Rejuvenation,” June 26, 2011
  37. Invited speaker, 2011 ASDS Annual Meeting, “Core Curriculum in Cosmetic Dermatologic Surgery Track: Neurotoxins,” Washington, DC, Nov. 2011
  38. Faculty, Cosmetic Surgery Forum, Las Vegas, NV, Dec. 2011
  39. Faculty, Dermaceutic Expert Meeting, Istanbul, Turkey, June, 2012
  40. Faculty, 2012 Vegas Cosmetic Surgery, June 2012
  41. Invited Speaker, 2012 ASDS Annual Meeting. “Core Curriculum in Cosmetic Dermatologic Surgery track: Neurotoxins,” Atlanta, GA, October 2012
  42. Invited Guest Speaker, “Treatment Strategies for Melasma and Hyperpigmentation,” Elure (Syneron Topical Aesthetics), Israeli Launch, Tel Aviv, Jerusalem, and Haifa, Israel, October, 2012
  43. Invited Speaker, Ultimate Skin Health Symposium, “Combination Treatments for Facial Rejuvenation,” Los Angeles, CA, Nov. 9-11, 2012
  44. Invited Speaker, International Master Course on Aging Skin (IMCAS), Paris, France, Jan. 30- Feb. 3, 2013
  45. Faculty, Innovations in Facial Aesthetics Workshop, Dallas TX, April 24, 2013, and Houston, TX, April 25, 2013
  46. Faculty, Cosmetic Surgery Forum, Las Vegas, NV, Nov.29-Dec. 2, 2013
  47. Invited Speaker, 5CC Cannes, Cannes, France, Sept 2013
  48. Faculty, Innovations in Facial Aesthetics Workshop, Austin, TX, Oct 2013
  49. Faculty, 2nd Annual DASIL Meeting, Bangkok, Thailand, Nov 2013
  50. Faculty, Cosmetic Surgery Forum, Las Vegas, NV, Nov.29-Dec. 2, 2013
  51. Faculty, Ulthera Workshop, Newport Beach, CA, Feb 27, 2014
  52. Faculty, PALETTE Workshop, San Antonio, TX, March 27, 2014
  53. Faculty, Ulthera Workshop, Houston, TX, April 24, 2014
  54. Invited Speaker, Australian Society of Aesthetic Plastic Surgery Nonsurgical Symposium 2014, Sydney, Australia, May 8-11, 2014
  55. Faculty, Vegas Cosmetic Surgery, Las Vegas, NV, June 18-22, 2014
  56. Faculty, Annual Meeting of the ASDS, San Diego, Nov 5-9, 2014
  57. Faculty, Cosmetic Surgery Forum, Las Vegas, Dec 4-7, 2014
  58. Speaker IMCAS Paris, France, Jan 2015
  59. Faculty, 73rd Annual Meeting of the AAD, San Francisco, CA, March 2014
  60. Keynote Speaker, Cosmetex 2015, Melbourne, Australia, April 2015
  61. Invited Speaker, FACE Meeting, London, UK, June 4-7, 2015
  62. Faculty and Steering Committee Member Vegas Cosmetic Surgery, Las Vegas, June 10-14, 2015
  63. Keynote Speaker Ultherapy European Speaker Tour London, Cologne, Paris, June 17-21, 2015
  64. Faculty, The Aesthetic Show, Las Vegas, July 2015
  65. Faculty, 5 Continents Congress (5CC) Cannes, France, Sept. 2015
  66. Faculty, Annual Meeting of the ASDS, Chicago, October 2015
  67. Faculty, 4th Annual Meeting DASIL, Ho Chi Minh City, Vietnam, Nov. 2015
  68. Faculty, Cosmetic Surgery Forum, Las Vegas, Dec. 2015
  69. Faculty, IMCAS Paris, 2016, Co-Chair Cosmeceuticals Course
  70. Faculty and Steering Committee Member Vegas Cosmetic Surgery, Las Vegas, June 8-12, 2016
  71. Faculty, Cosmetic Bootcamp, Aspen, July 7-10, 2016
  72. Faculty, 5 CC Barcelona, Aug.31 – Sept 4, 2016
  73. Faculty, Annual Meeting of the ASDS, New Orleans, 2016
  74. Faculty, Annual Meeting of the ASDS, New Orleans, 2016
  75. Speaker, ODAC, Miami FL, Jan. 14, 2017
  76. Faculty, IMCAS, Paris, Jan. 2017
  77. Faculty, Vegas Cosmetic Surgery, Las Vegas, NV, June 2017
  78. Faculty and co-chair for session Core Curriculum on Chemical Peels, Annual Meeting of the ASDS, Chicago 2017
  79. Invited Speaker, Cosmetic Update, Riviera Maya, Mexico, November 2017
  80. Faculty, ODAC, Miami FL, January 2018
  81. Faculty, SCALE, Nashville, TN, May 2018
  82. Faculty, 5 CC Barcelona August 31- September 2, 2018
  83. Faculty and lead co-chair for session Core Curriculum on Chemical Peels, Annual Meeting of the ASDS, Phoenix, AZ, October 2018
  84. Faculty, DASIL, Buenos Aires, Oct. 31 – Nov. 3, 2018
  85. Faculty, Cosmetic Surgery Forum, Las Vegas, NV, Nov. 27 – Dec. 2, 2018
  86. Invited speaker Fall Meeting of the Texas Dermatological Society, San Anton
  87. Faculty and course director for Cosmeceuticals Master Class, Annual Meeting of the ASDS, Chicago, IL, October 2019 
  88. Faculty, Cosmetic Surgery Forum, Nashville, TN, Dec. 2019
  89. Faculty and co-chair of Cosmeceuticals Master Class, International Master Course On Aging Science (IMCAS) Paris, Jan. 30- Feb.1, 2020

Community Service:

The mission of Respite Care of San Antonio is to protect, love, build trust, and nurture the growth of children with special needs and complex medical conditions while strengthening the families caring for them.

2007

Publications, Lectures and Presentations:

  1. Wasserteil, V. Bruce, 5: Fever and hypotrichosis in a newborn. Arch Dermatol. 1986. 122:1325-1330.
  2. Wasserteil, V. Bruce, 5: Ricardi, VM: Non-von Recklinghausen’s neurofibromatosis presenting as hemifacial neurofibromas and contralateral cafd-au-lait- spots. J Am Acad Dermatol, 1987. 16:1090-1096.
  3. Wasserteil, V. Jimenez-Acosta, FJ. Kerdel, FA: Disseminated histoplasmosis presenting as a rosacea-like eruption in a patient with the acquired immunodeficiency syndrome. Inter. J. Dermatol. 1990.29:649-651.
  4. Wasserteil, V. Kerdel, FA: A case of Erythema Dyschromicum Perstans. Self-Assessment. Examination for the American Academy of Dermatology. JAm Acad Dermatol. 1989. 21:604-608
  5. Mertz, PM. Marshall, DA. Cazzaniga, AL. Wasserteil, V. Eaglstein, WH: The effects of a new antimicrobial peptide magainin on pseudomonas aeruginosa proliferation in wounds (Abstract). J Invest Dermatol. 1990. 94:555.
  6. Wasserteil, V. Bruce, S: Fievre et hypotrichose chez un noouveau-ne. Les cases cliniques des archives of dermatology. 1990. 2:19-21.
  7. Wasserteil, V. Bruce, 5, Sessoms SL, et al. Pyoderma gangrenosum treated with hyperbaric oxygen therapy. Int J Dermatol 1992. 31:594-6.
  8. Bucay, VW: Ironic Diagnosis ‘Changes Life Forever’. San Antonio Medicine. 2006. 59(10):32-33
  9. Bucay, VW: A Dermatologist’s Battle with Melanoma. The Skin Cancer Foundation Journal. 2008. XXVI:52-56
  10. Bucay, VW: Surviving Advanced Melanoma: A Dermatologist’s Personal Perspective. The Melanoma Letter, Vol. 26, No. 3, 2008
  11. Bucay, V: Building the Skin Care Regimen: Choosing the right ingredients. Practical Dermatology. Feb. 2011, p. 31-38.
  12. Maas C, Kane MAC, Bucay VW, et al. Current Aesthetic Use of AbobotulinumtoxinA in Clinical Practice: An Evidence-Based Consensus Review. Aesthet Surg J 2012; 32:8S-29S.
  13. Bucay VW, Day D. Adjunctive Skin Care of the Periorbital Region and Brow. Clin Plastic Surg, 2013; 40: 225-236.
  14. Vega JM, Bucay VW, Mayoral FA. Prospective, Multicenter Study to Determine the Safety and Efficacy of a Unique Radiofrequency Device for Moderate to Severe Hand Wrinkles. J Drugs Dermatol. 2013; 12(1): 24-26.
  15. Nestor M, Bucay V, Callender V, et al. Polypodium leucotomos as an Adjunct Treatment of Pigmentary Disorders. J Clin Aesthet Dermatol. 2014; 7(3): 4-44.
  16. Gold MH, Kircik LH, Bucay VB, et al. Treatment of Facial Photodamage Using a Novel Retinol Formulation. J Drugs Dermatol. 2013; 12(5): 533-541.
  17. Bucay VW, Fillers and Injectables: A Historical Perspective. J Drugs Dermatol. 2014; 13(9): 1010-1012
  18. Gallo RL, Bucay VW, Shamban AT, et al. The Potential Role of Topically Applied Heparan Sulfate in the Treatment of Photodamage. J Drugs Dermatol. 2015; 14(7): 669-674.
  19. McDaniel DH, Hamzavi IH, Zeichner JA, Fabi SG, Bucay VW, et al. Total Defense and Repair: A Novel Concept in Solar Protection and Skin Rejuvenation. J Drugs Dermatol. 2015; 14 (suppl 7): s3- s11.
  20. Hornfeldt CS, Holland M. Panel Discussion with Vivian W Bucay MD, Wendy E Roberts MD, Heidi A Waldorf MD, and Steven H Dayan, MD. The Safety and Efficacy of a Sustainable Marine Extract for the Treatment of Thinning Hair: A Summary of New Clinical Research. J Drugs Dermatol. 2015;14 (9 suppl): s15-s22.
  21. Narurkar VA, Fabi SG, Bucay VW, Tedaldi R, et al. Rejuvenating Hydrator: Restoring Epidermal Hyaluronic Acid Homeostasis with Instant Benefits. J Drugs Dermatol. 2016; 15(suppl 2): s24-s37.
  22. Widgerow, AD, Fabi SG, Palestine RF, Rivkin A, Ortiz A, Bucay VW, et al. Extracellular Matrix Modulation: Optimizing Skin Care and Rejuvenation Procedures. J Drugs Dermatol. 2016;15(suppl 4): s63 – s71.
  23. Taub, A, Bucay V, Keller G, et al. Multi-Center, Double-Blind, Vehicle-Controlled Clinical Trial of an Alpha and Beta Defensin-Containing anti-aging Skin Care Regimen With Clinical, Histopathologic, Immunohistochemical, Photographic, and Ultrasound Evaluation. J Drugs Dermatol 2018; 17(4): 426-441.
  24. Stephens TJ, Babcock M, Bucay V, Gotz V. Split-face Evaluation of a Multi-ingredient Brightening Foam Versus a Reference Control in Women with Photodamaged Facial Skin. J Clin Aesthet Dermatol. 2018; 11(10): 24-28
  25. Fabi S, Montes JR, Aguilera SB, Bucay V, et al. Understanding the Female Hispanic and Latino American Facial Aesthetic Patient. J Drugs Dermatol. 2019; 18(7): 217-226.
    1. Bucay V, Chemical Peeling book chapter for Moschella’s Textbook of Dermatology, in Press, 2019

PRESENTATIONS (during post-graduate training)

  1. Wasserteil, V. Jimenez- Acosta, FJ. Kerdel, FA: Disseminated Histoplasmosis Resembling Rosacea in a Patient with AIDS. Gross and Microscopic Symposium. 48” Annual Meeting of the American Academy of Dermatology. December 2, 1989.
  2. Wasserteil, V. Bruce, S. Fehir, K. Sessoms, 5: Dermatomyositis- like Eruption Associated with Chemotherapy for Non-Hodgkin’s Lymphoma. 22 Annual Meeting of the South Central Dermatology Congress. January 28, 1990.
  3. Wasserteil, V. Levy, ML: Benign Cephalic Histiocytosis. Gross and Microscopic Symposium. 49th Annual Meeting of the American Academy of Dermatology. December 1, 1990.
  4. Mertz, PM. Marshall, DA. Cazzaniga, AL. Wasserteil, V. Berkowitz, B: Effect of a topical magainin on Pseudomonas aeruginosa proliferation in wounds. (Poster) American Society of investigative Dermatology. May 2-5, 1990.
  5. Mertz, PM. Marshall, DA. Cazzaniga, AL. Wasserteil, V. Eaglstein, WH. Berkowitz, B: Effect of a topical magainin on Pseudomonas aeruginosa proliferation in wounds. (Poster) American Society of Microbiology. May 1990.
  6. Mertz, PM. Marshall, DA. Cazzaniga, AL Wasserteil, V. Eaglstein, WH. Berkowitz, B: Effect of a topical magainin on Pseudomonas aeruginosa proliferation in wounds. (Poster) 49th Annual Academy of Dermatology. December 1-6, 1990.

RESEARCH /STUDIES

  1. Enzyme Kinetics and the Relationship of Beta-Glucuronnidase Release to Platelet Viability in Stored and Frozen Platelet Concentrates (under J.P. Hester, M.D.). Summer Program in Biomedical sciences at M.D. Anderson Hospital and Tumor Institute, Houston, Texas. 1979.
  2. The effects of Anticoagulants on in vitro Lymphocyte Transformation (under J.P. Hester, M.D.). M.D. Anderson Hospital and Tumor Institute, Houston, Texas. 1980-1981.
  3. Research Assistant at the Johns Hopkins Oncology Center, Baltimore, M.D. (under R, Tucker, M.D., Ph D.) 1982-1983.
  4. Androgen Receptors in Becker’s Nevus (under S. Bruce, M.D.). Baylor College of Medicine, Houston, Texas. 1986.
  5. Topical Magainins in the Treatment of Infected Skin Wounds (under William H. Eaglstein, M.D.) University of Miami School of Medicine, Department of Dermatology, Miami, Florida 1988-1989.
  6. An open-label. Non-Controlled Study of Calcipotriol (MC903/bmy 30434) Ointment (0.005%) in the Long-Term Treatment of Plaque Psoriasis. Baylor College of Medicine. Houston, Texas.
  7. Controlled Trial Comparing Sulconazole Nitrate/Hydrocortisone Valerate Gel, Sulconazole Nitrate Gel and Hydrocortisone Valerate Gel in the Treatment of Tinea Pedis. Baylor College of Medicine. Houston, Texas.
  8. Double Blind, Bilateral, Paired Comparison Study of Ultravate Ointment 0.05% in the Treatment of Plaque Psoriasis. Baylor College of Medicine. Houston, Texas.
  9. Prospective, Multicenter Study to determine the Safety and Efficacy of a Unique Rediofrequency Device on Moderate to Severe Hand Wrinkles. Miami, Florida and San Antonio, Texas, 2011.

Newsletters:

www.drvivianbucay.com,

Educational Background:

UndergraduateJohns Hopkins University (full scholarship)

Baltimore, MD

Aug 1979 – May 1983

Bachelor of Arts in Natural Sciences

Medical School

Baylor College of Medicine

Houston, TXAug 1983 – June 1987

Medical Doctorate

Internship

Baylor College of Medicine

Houston, TX

July 1987 – June 1988

Internship, Pediatrics

Residency

University of Miami School of Medicine

Miami, FL

July 1988 – June 1989

First-year Residency in Dermatology

Residency

Baylor College of Medicine

Houston, TX

July 1989 – June 1991

Residency in Dermatology

Honors
National Merit Scholar (1979)

Phi Beta Kappa (1979-1983)

Teamster International Scholarship (1979-1983)

Baylor Trustee Scholarship (1985)


Map Location

Additional Locations

BUCAY-Center for Dermatology and Aesthetics
18707 Hardy Oak Blvd, Suite 101
Hardy Oak Medical Pavilion
San Antonio, Te 78258
210.370.9995

Latest from Vivian W. Bucay's Blog

There was a problem parsing this feed

What is Super Doctors?
Super Doctors Magazine

Super Doctors identifies top doctors as selected by their peers and the independent research of MSP Communications. Please note: Doctors cannot pay to be included on Super Doctors® listings nor are they paid to provide input.

Super Doctors is published online and also in print as a special advertising section in leading newspapers and city and regional magazines.

Click here for more details